1 Introduction to Research & Analysis Reports
    1.1 Breakthrough Therapy (BT) Designation Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Breakthrough Therapy (BT) Designation Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Breakthrough Therapy (BT) Designation Overall Market Size
    2.1 Global Breakthrough Therapy (BT) Designation Market Size: 2021 VS 2027
    2.2 Global Breakthrough Therapy (BT) Designation Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Breakthrough Therapy (BT) Designation Players in Global Market
    3.2 Top Global Breakthrough Therapy (BT) Designation Companies Ranked by Revenue
    3.3 Global Breakthrough Therapy (BT) Designation Revenue by Companies
    3.4 Top 3 and Top 5 Breakthrough Therapy (BT) Designation Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Breakthrough Therapy (BT) Designation Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Breakthrough Therapy (BT) Designation Players in Global Market
        3.6.1 List of Global Tier 1 Breakthrough Therapy (BT) Designation Companies
        3.6.2 List of Global Tier 2 and Tier 3 Breakthrough Therapy (BT) Designation Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Breakthrough Therapy (BT) Designation Market Size Markets, 2021 & 2027
        4.1.2 Oncology
        4.1.3 Infectious Diseases
        4.1.4 Rare Diseases
        4.1.5 Autoimmune Diseases
        4.1.6 Pulmonary Diseases
        4.1.7 Neurological Disorders
        4.1.8 Others
    4.2 By Type - Global Breakthrough Therapy (BT) Designation Revenue & Forecasts
        4.2.1 By Type - Global Breakthrough Therapy (BT) Designation Revenue, 2016-2021
        4.2.2 By Type - Global Breakthrough Therapy (BT) Designation Revenue, 2022-2027
        4.2.3 By Type - Global Breakthrough Therapy (BT) Designation Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Breakthrough Therapy (BT) Designation Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Research Institute
        5.1.5 Laboratories
        5.1.6 Others
    5.2 By Application - Global Breakthrough Therapy (BT) Designation Revenue & Forecasts
        5.2.1 By Application - Global Breakthrough Therapy (BT) Designation Revenue, 2016-2021
        5.2.2 By Application - Global Breakthrough Therapy (BT) Designation Revenue, 2022-2027
        5.2.3 By Application - Global Breakthrough Therapy (BT) Designation Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Breakthrough Therapy (BT) Designation Market Size, 2021 & 2027
    6.2 By Region - Global Breakthrough Therapy (BT) Designation Revenue & Forecasts
        6.2.1 By Region - Global Breakthrough Therapy (BT) Designation Revenue, 2016-2021
        6.2.2 By Region - Global Breakthrough Therapy (BT) Designation Revenue, 2022-2027
        6.2.3 By Region - Global Breakthrough Therapy (BT) Designation Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Breakthrough Therapy (BT) Designation Revenue, 2016-2027
        6.3.2 US Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.3.3 Canada Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.3.4 Mexico Breakthrough Therapy (BT) Designation Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Breakthrough Therapy (BT) Designation Revenue, 2016-2027
        6.4.2 Germany Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.4.3 France Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.4.4 U.K. Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.4.5 Italy Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.4.6 Russia Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.4.7 Nordic Countries Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.4.8 Benelux Breakthrough Therapy (BT) Designation Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Breakthrough Therapy (BT) Designation Revenue, 2016-2027
        6.5.2 China Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.5.3 Japan Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.5.4 South Korea Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.5.5 Southeast Asia Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.5.6 India Breakthrough Therapy (BT) Designation Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Breakthrough Therapy (BT) Designation Revenue, 2016-2027
        6.6.2 Brazil Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.6.3 Argentina Breakthrough Therapy (BT) Designation Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Breakthrough Therapy (BT) Designation Revenue, 2016-2027
        6.7.2 Turkey Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.7.3 Israel Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.7.4 Saudi Arabia Breakthrough Therapy (BT) Designation Market Size, 2016-2027
        6.7.5 UAE Breakthrough Therapy (BT) Designation Market Size, 2016-2027
7 Players Profiles
    7.1 Roche
        7.1.1 Roche Corporate Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Breakthrough Therapy (BT) Designation Major Product Offerings
        7.1.4 Roche Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.1.5 Roche Key News
    7.2 Abbvie
        7.2.1 Abbvie Corporate Summary
        7.2.2 Abbvie Business Overview
        7.2.3 Abbvie Breakthrough Therapy (BT) Designation Major Product Offerings
        7.2.4 Abbvie Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.2.5 Abbvie Key News
    7.3 Novartis International AG
        7.3.1 Novartis International AG Corporate Summary
        7.3.2 Novartis International AG Business Overview
        7.3.3 Novartis International AG Breakthrough Therapy (BT) Designation Major Product Offerings
        7.3.4 Novartis International AG Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.3.5 Novartis International AG Key News
    7.4 Janssen
        7.4.1 Janssen Corporate Summary
        7.4.2 Janssen Business Overview
        7.4.3 Janssen Breakthrough Therapy (BT) Designation Major Product Offerings
        7.4.4 Janssen Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.4.5 Janssen Key News
    7.5 BMS
        7.5.1 BMS Corporate Summary
        7.5.2 BMS Business Overview
        7.5.3 BMS Breakthrough Therapy (BT) Designation Major Product Offerings
        7.5.4 BMS Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.5.5 BMS Key News
    7.6 Eli Lilly
        7.6.1 Eli Lilly Corporate Summary
        7.6.2 Eli Lilly Business Overview
        7.6.3 Eli Lilly Breakthrough Therapy (BT) Designation Major Product Offerings
        7.6.4 Eli Lilly Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.6.5 Eli Lilly Key News
    7.7 Gilead
        7.7.1 Gilead Corporate Summary
        7.7.2 Gilead Business Overview
        7.7.3 Gilead Breakthrough Therapy (BT) Designation Major Product Offerings
        7.4.4 Gilead Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.7.5 Gilead Key News
    7.8 Sanofi
        7.8.1 Sanofi Corporate Summary
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Breakthrough Therapy (BT) Designation Major Product Offerings
        7.8.4 Sanofi Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.8.5 Sanofi Key News
    7.9 Regeneron
        7.9.1 Regeneron Corporate Summary
        7.9.2 Regeneron Business Overview
        7.9.3 Regeneron Breakthrough Therapy (BT) Designation Major Product Offerings
        7.9.4 Regeneron Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.9.5 Regeneron Key News
    7.10 Acadia
        7.10.1 Acadia Corporate Summary
        7.10.2 Acadia Business Overview
        7.10.3 Acadia Breakthrough Therapy (BT) Designation Major Product Offerings
        7.10.4 Acadia Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.10.5 Acadia Key News
    7.11 Boehringer Ingelheim
        7.11.1 Boehringer Ingelheim Corporate Summary
        7.11.2 Boehringer Ingelheim Business Overview
        7.11.3 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Major Product Offerings
        7.11.4 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.11.5 Boehringer Ingelheim Key News
    7.12 Amgen
        7.12.1 Amgen Corporate Summary
        7.12.2 Amgen Business Overview
        7.12.3 Amgen Breakthrough Therapy (BT) Designation Major Product Offerings
        7.12.4 Amgen Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.12.5 Amgen Key News
    7.13 AstraZeneca
        7.13.1 AstraZeneca Corporate Summary
        7.13.2 AstraZeneca Business Overview
        7.13.3 AstraZeneca Breakthrough Therapy (BT) Designation Major Product Offerings
        7.13.4 AstraZeneca Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.13.5 AstraZeneca Key News
    7.14 GlaxoSmithKline
        7.14.1 GlaxoSmithKline Corporate Summary
        7.14.2 GlaxoSmithKline Business Overview
        7.14.3 GlaxoSmithKline Breakthrough Therapy (BT) Designation Major Product Offerings
        7.14.4 GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.14.5 GlaxoSmithKline Key News
    7.15 Vertex
        7.15.1 Vertex Corporate Summary
        7.15.2 Vertex Business Overview
        7.15.3 Vertex Breakthrough Therapy (BT) Designation Major Product Offerings
        7.15.4 Vertex Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.15.5 Vertex Key News
    7.16 Alexion
        7.16.1 Alexion Corporate Summary
        7.16.2 Alexion Business Overview
        7.16.3 Alexion Breakthrough Therapy (BT) Designation Major Product Offerings
        7.16.4 Alexion Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.16.5 Alexion Key News
    7.17 Merck
        7.17.1 Merck Corporate Summary
        7.17.2 Merck Business Overview
        7.17.3 Merck Breakthrough Therapy (BT) Designation Major Product Offerings
        7.17.4 Merck Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.17.5 Merck Key News
    7.18 Jazz Pharmaceuticals
        7.18.1 Jazz Pharmaceuticals Corporate Summary
        7.18.2 Jazz Pharmaceuticals Business Overview
        7.18.3 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Major Product Offerings
        7.18.4 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.18.5 Jazz Pharmaceuticals Key News
    7.19 Exelixis
        7.19.1 Exelixis Corporate Summary
        7.19.2 Exelixis Business Overview
        7.19.3 Exelixis Breakthrough Therapy (BT) Designation Major Product Offerings
        7.19.4 Exelixis Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.19.5 Exelixis Key News
    7.20 Eisai
        7.20.1 Eisai Corporate Summary
        7.20.2 Eisai Business Overview
        7.20.3 Eisai Breakthrough Therapy (BT) Designation Major Product Offerings
        7.20.4 Eisai Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.20.5 Eisai Key News
    7.21 Takeda
        7.21.1 Takeda Corporate Summary
        7.21.2 Takeda Business Overview
        7.21.3 Takeda Breakthrough Therapy (BT) Designation Major Product Offerings
        7.21.4 Takeda Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.21.5 Takeda Key News
    7.22 Pfizer
        7.22.1 Pfizer Corporate Summary
        7.22.2 Pfizer Business Overview
        7.22.3 Pfizer Breakthrough Therapy (BT) Designation Major Product Offerings
        7.22.4 Pfizer Breakthrough Therapy (BT) Designation Revenue in Global (2016-2021)
        7.22.5 Pfizer Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer